Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Takeda
Related studies linked through entity extraction aliases.
Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Application of Tachosil During Lymphadenectomy
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Daratumumab in Combination With Ixazomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune Adults
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel and TAK-228 in Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease
- Status
- COMPLETED
- Phase
- PHASE2
Ph 2 Maintenance Trial: Ixazomib vs Ixazomib-Lenalidomide for MM Patients
- Status
- TERMINATED
- Phase
- PHASE2
Myeloma-Developing Regimens Using Genomics (MyDRUG)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma"
- Status
- COMPLETED
- Phase
- N/A
Rasagiline Tablets Special Drug Use-Results Survey "Survey on Long-term Safety"
- Status
- COMPLETED
- Phase
- N/A
Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis
- Status
- TERMINATED
- Phase
- NA
Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE3
A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants
- Status
- COMPLETED
- Phase
- N/A
Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate the Relative Bioavailability (BA) and Effect of Food on TAK-831 Tablet Formulations in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Phase 3 Study of Cx601 in Participants With Complex Perianal Fistulising Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)
- Status
- COMPLETED
- Phase
- PHASE2